4//SEC Filing
Mannick Joan 4
Accession 0000899243-19-028707
CIK 0001720580other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 5:24 PM ET
Size
8.5 KB
Accession
0000899243-19-028707
Insider Transaction Report
Form 4
resTORbio, Inc.TORC
Mannick Joan
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-12-06+88,667→ 88,667 totalExercise: $1.27Exp: 2029-12-05→ Common Stock (88,667 underlying) - Award
Common Stock
2019-12-06+118,222→ 1,404,585 total
Holdings
- 600,000(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The Reporting Person was issued Restricted Stock Units ("RSU"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest in four (4) annual installments, with the first tranche vesting on December 6, 2020. The RSUs may be settled only by delivering shares of common stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
- [F2]Shares held by the J.B. Mannick Irrevocable Trust (the "Trust"). The reporting person disclaims Section 16 beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose
- [F3]25% of the shares shall vest on December 6, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
resTORbio, Inc.
CIK 0001720580
Entity typeother
Related Parties
1- filerCIK 0001727384
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 5:24 PM ET
- Size
- 8.5 KB